Distribution of the serotonin 2C (5HT2C) receptor gene - 759C/T polymorphism in patients with schizophrenia and normal controls

Psychiatric Genetics

Volumn 14, Issue 2, 2004, Pages 93-95

  Ellingrod, Vicki L ^a,c   Miller, Del ^b   Ringold, John C ^b   Perry, Paul J ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c NONE   (United States)

Author keywords

Diabetes mellitus; Polymorphisms; Schizophrenia; Serotonin receptor

Indexed keywords

SEROTONIN RECEPTOR;

ARTICLE; CHI SQUARE TEST; CONTROLLED STUDY; DNA DETERMINATION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; HUMAN; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE;

CYTOSINE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HUMANS; IOWA; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, SEROTONIN, 5-HT2C; REFERENCE VALUES; SCHIZOPHRENIA; THYMINE;

EID: 2942666137     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ypg.0000107930.32051.8e     Document Type: Article

References (11)

1. Dixon L, Weiden P, Delahanty J, et al. (2000). Prevalence and correlates of diabetes in national schizophrenia samples. Schizophr Bull 26:903-912.
2. Dynes JB (1969). Diabetes in schizophrenia and diabetes in nonpsychotic medical patients. Dis Nerv Syst 30:341-344.
3. Ellingrod VL, Perry PJ, Ringold JC, Lund BL, Bever-Stille K, Fleming F, et al. Weight gain associated with the -759 C/T polymorphism of the 5HT2C receptor and olanzapine. Am J Med Genet.
4. Kenny SJ, Aubert RE, Geiss LS (1995). Prevalence and incidence of non-insulin-dependant diabetes. In: Harris MI, Cowie CC, Stern MP, Boyko EJ, Reiber GE, Bennett PH (editors). Diabetes in American, 2nd edition. National Diabetes Data Group, National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Bethesda, MN, USA: NIH publication number 95-1468; pp. 47-67. Also at http://diabetes.niddk.nih. gov/dm/pubs/america/pdf/editorialboard.pdf
5. Lappalainen J, Zhang L, Den M, Oz M, Ozaki N, Yu-D-H, et al. (1995). Identification, expression, and pharmacology of a Cys23-Ser23 substitution in the human 5-HT2C receptor gene (HTR2C). Genomics 27:274-279.
6. McKee HA, D'Arcy PF, Wilson PJ (1986). Diabetes and schizophrenia - a preliminary study. J Clin Hosp Pharmacol 11:297-299.
7. Mukherjee S, Decina P, Bocola V, Saraceni F, Scapicchio PL (1996). Diabetes mellitus in schizophrenic patients. Comparative Psychiatry 37:68-73.
8. Reynolds GP, Zhang AJ, Zhang XB (2002). Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism. Lancet 359:2086-2087.
9. Reynolds GP, Zhang AJ, Zhang XB (2003). Polymorphism of the promoter region of the serotonin 5-HT2C receptor gene and clozapine-induced weight gain. Am J Psychiatry 160:677-679.
10. Shih JC, Zhu Q, Chen K (1996). Determination of transcription initiation sites and promoter activity of the human 5-HT2A receptor gene. Behav Brain Res 73:59-62.
11. Yuan X, Yamada K, Ishiyama-Shigemoto S, Koyama W, Nonaka K (2000). Identification of a polymorphic loci in the promoter region of the serotonin 5-HT 2C receptor gene and their association with obesity and type II diabetes. Diabetologia 43:373-376.